Table 2 Difference between 25-hydroxyvitamin D deficiency and normal 25-hydroxyvitamin in hypertensive subjects

From: Association of serum 25-hydroxyvitamin D levels with primary hypertension: a study from south India

Parameters

Vitamin D deficiency (n = 164)

Normal vitamin D (n = 236)

p value

Men

99 (60%)

156 (39%)

0.2

Mean age

53.4 ± 3.7

51.7 ± 9.5

 

Age range

45–85

45–87

 

Diabetics

57 (34.7%)

84 (35.5%)

0.9

Smoking

14 (8.5%)

10 (4.2%)

0.1

Alcoholics

21 (12.8%)

24 (10.1%)

0.5

Dyslipidemia

58 (35.3%)

78 (33%)

0.7

CRP positive

77 (46.9%)

91 (38.5%)

0.1

≤24.9 BMI (kg/m2)

121 (73.7%)

169 (71.6%)

0.1

25–30 BMI (kg/m2)

27 (16.4%)

53 (22.4%)

0.1

Obesity ≥30.1 BMI (kg/m2)

16 (9.7%)

14 (5.9%)

0.1

Elevate alanine transaminase (ALT) levels

62 (37.8%)

58 (24.5%)

0.0064

Elevate aspartate transaminase (AST) levels

48 (29%)

50 (21.1%)

0.08

Mean parathyroid hormone (PTH)

70.4 ± 15.5

67.6 ± 17.2

0.09

Mean duration of hypertension

3.5 ± 2.9

3.3 ± 2.9

=0.02

Mean systolic blood pressure

151.8 ± 18.2

141.2 ± 10.2

<0.0001

Mean diastolic blood pressure

97.4 ± 8.4

89.5 ± 7.5

<0.0001

Seasonal variations

 Summer

98 (59.7%)

131 (55.5%)

0.4

 Winter

66 (40.2%)

105 (44.4%)

0.4